CHIVA Is Entering a More Organized Phase of Global Expansion

Key Points

Program basis: APCA describes the Global CHIVA Program as a global education, training, and assessment platform for the diagnosis and treatment of venous insufficiency, and as the first globally recognized standard for mastering the CHIVA technique.
Organizational framework: The program is being advanced through collaboration between Inteleos and Dr. Smile Medical Group. Public information shows that the Tier 1 pilot soft launch has released its first two foundational modules.
Clinical significance: This suggests that the development of CHIVA is moving beyond journal articles and procedural discussion into a more structured stage of education, assessment, and certification.

In the spread of CHIVA, what many people have known best are published papers, case reports, procedural comparisons, and discussions centered on hemodynamic logic. But if a treatment pathway is truly going to enter broader clinical practice, the questions it faces will not stop at whether supporting literature exists. It will also enter another level: who teaches it, how it is learned, how it is assessed, and how a shared standard is built.

That is why the Global CHIVA Program deserves attention. According to APCA, the program is designed as a global platform for education, training, and assessment in venous insufficiency, with the aim of establishing a recognizable and certifiable framework for learning and mastering CHIVA worldwide.

1. Program Background and Structure

From APCA’s official description, the Global CHIVA Program is not simply a course offering. It is presented as a tiered framework intended to support CHIVA education, training, and competency assessment on a global scale. APCA describes it as a “groundbreaking medical education, training, and assessment platform” and states that it is building “the first globally recognized and certified standard for mastering the CHIVA technique.”

This means the discussion is no longer limited to whether an individual physician can perform CHIVA. It moves one step further, toward a larger question: if CHIVA is to expand globally, can it be taught and evaluated through a more unified training and certification system?

Public information also shows that the program is being advanced through collaboration between Inteleos and Dr. Smile Medical Group. Inteleos noted that the Tier 1 Pilot Soft Launch in December 2025 marked a first step toward a unified global framework for standardized education, assessment, and certification.

Inteleos has also stated that the two organizations had already begun working together on global CHIVA standards, certification, education, and training as early as 2022.

2. What the Program Is Signaling at This Stage

What stands out in the currently available information is not only that courses have been launched, but that the program is trying to move CHIVA from fragmented transmission toward structured training.

APCA states that Tier 1 currently includes two foundational modules. Inteleos further notes that the first modules released during the soft launch are Fundamentals of Ultrasound Knowledge and Device Operation and Fundamentals of Venous Hemodynamics.

Those two modules are highly revealing in themselves. They do not begin with a specific operative maneuver. They begin with ultrasound fundamentals and venous hemodynamics. In other words, the program is sending a clear message: mastering CHIVA should not be understood as copying a local technical move, but as building competence on more fundamental skills of assessment and judgment.

APCA also notes that the program uses a tiered framework. Inteleos adds that the soft launch phase includes open participation, ongoing refinement of content and assessment, and direct incorporation of user feedback into future optimization.

That suggests this is not a one-time release of educational content, but the early construction of a more complete standardized pathway.

3. Clinical Perspective: From Knowing CHIVA to Training CHIVA Systematically

Placed in the broader context of CHIVA’s development, the significance of this initiative lies not only in the program launch itself, but in the way CHIVA is now being transmitted.

In the past, CHIVA spread largely through a limited number of centers, physicians, and publication nodes. What the Global CHIVA Program represents is a different model: through structured coursework, unified assessment, and certification mechanisms, CHIVA is moving from simply being “known” to being systematically taught.

That matters. CHIVA has never been a pathway that can be performed reliably by memorizing a few technical steps alone. It involves ultrasound, hemodynamics, pathophysiologic understanding, and clinical judgment. Without systematic training, the method can easily be reduced to fragments, or even misapplied. What the Global CHIVA Program appears to be doing is turning that methodological threshold into something more teachable, transferable, and assessable.

For that reason, the signal coming from this project is not simply that CHIVA is receiving more attention. It is that CHIVA is entering a more organized phase of global expansion. Once education, training, and certification begin to take shape within a common framework, what changes is not only the range of dissemination, but the way the method itself is understood, learned, and implemented.

Sources

APCA. Global CHIVA Program. Alliance for Physician Certification & Advancement.

Inteleos. Shaping the Future of Venous Care Education with CHIVA: Globally, Patient-First and Proven. Jan 8, 2026.

Inteleos. Inteleos and Dr. Smile Medical Group Celebrate One-Year Strategic Partnership. May 24, 2022.

Note

This article is based on publicly available information and is intended for professional communication and content reference only. It does not constitute medical advice.

CHIVA Is Entering a More Organized Phase of Global Expansion